Classement en actions
#39206
hVIVO plc (HVO) operates as a premier full-service Contract Research... hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of clinical development services to a wide-ranging and growing client base, which includes seven of the world's ten largest biopharmaceutical companies. A key specialisation for hVIVO is orchestrating human challenge trials across numerous infectious and respiratory diseases, utilising its advanced, London-based quarantine facility, the largest of its kind globally. Additionally, the company offers extensive virology and immunology laboratory services through its hLAB division. Through its German subsidiary, CRS, hVIVO manages a 120-bed capacity across sites in Mannheim and Kiel, delivering early-phase clinical trial expertise, including first-in-human and proof-of-concept studies. Its other subsidiary, Venn Life Sciences, contributes to the biopharma sector by providing specialist early drug development consulting and biometry services. The Group collectively offers integrated drug development solutions, covering stages from preclinical research up to Phase II trials, supported by patient recruitment via FluCamp. Moreover, its five clinical sites facilitate outpatient Phase II and III trials, ensuring a streamlined and effective transition from drug discovery to late-stage development.
Prix de l'action
$0.0903846
Capitalisation boursière
$622.21K
Changement (1 jour)
-0.86%
Changement (1 an)
-34.82%
EPS pour HVIVO plc (HVO)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de HVIVO plc, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de HVIVO plc de 2026 à 2026
EPS à la fin de chaque année
| Année |
EPS |
Changez |
|
Pas assez de données pour les dates fournies. |
EPS pour des entreprises ou concurrents similaires
| Entreprise |
EPS |
Différence d’EPS |
Pays |
|
|
$17.32 |
-
|
US
|
|
|
$27.74 |
-
|
NL
|
|
|
- |
-
|
CH
|
|
|
- |
-
|
KR
|
|
|
$13.70 |
-
|
BE
|
